Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (321-330 of 1,860) with videos related to

Pageof 186
Sort By:
Journal of Clinical Pharmacology|July 1, 1989
Clinical utility of nifedipine and diltiazem plasma levels in patients with angina pectoris receiving monotherapy and combination treatmentJ Goldberger, W H Frishman
Cardiology in Review|February 4, 2012
Cardiovascular pharmacologic therapies under investigation: 2012William H Frishman, Kalyana Pallerla
Cardiology in Review|December 8, 2010
Vernakalant: a new drug to treat patients with acute onset atrial fibrillationDavid Tian, William H Frishman
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2011
β-Adrenergic blockersWilliam H Frishman, Elijah Saunders
Cardiology in Review|January 26, 2016
The Subcutaneous Implantable Cardioverter DefibrillatorDaniel Mangels, William H Frishman
Cardiology in Review|December 12, 2018
Cardiac Applications of Dual-Energy Computed TomographyMatthew Lempel, William H Frishman
Cardiology in Review|July 22, 2021
Implications of Frailty in COVID-19Curtis Lee, William H Frishman
Cardiology in Review|September 17, 2020
Association Between Arsenic Exposure and Cardiovascular DiseaseMariya Kononenko, William H Frishman
Journal of Minimally Invasive Gynecology|January 23, 2022
What's in a Beta?Karine Matevossian, Gary N Frishman
Drugs|March 20, 2015
Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonistsDaniel Glicklich, William H Frishman
Pageof 186

Showing results (321-330 of 1,860) with videos related to

Sort By:
Pageof 186
Journal of Clinical Pharmacology|July 1, 1989
Clinical utility of nifedipine and diltiazem plasma levels in patients with angina pectoris receiving monotherapy and combination treatmentJ Goldberger, W H Frishman
Cardiology in Review|February 4, 2012
Cardiovascular pharmacologic therapies under investigation: 2012William H Frishman, Kalyana Pallerla
Cardiology in Review|December 8, 2010
Vernakalant: a new drug to treat patients with acute onset atrial fibrillationDavid Tian, William H Frishman
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2011
β-Adrenergic blockersWilliam H Frishman, Elijah Saunders
Cardiology in Review|January 26, 2016
The Subcutaneous Implantable Cardioverter DefibrillatorDaniel Mangels, William H Frishman
Cardiology in Review|December 12, 2018
Cardiac Applications of Dual-Energy Computed TomographyMatthew Lempel, William H Frishman
Cardiology in Review|July 22, 2021
Implications of Frailty in COVID-19Curtis Lee, William H Frishman
Cardiology in Review|September 17, 2020
Association Between Arsenic Exposure and Cardiovascular DiseaseMariya Kononenko, William H Frishman
Journal of Minimally Invasive Gynecology|January 23, 2022
What's in a Beta?Karine Matevossian, Gary N Frishman
Drugs|March 20, 2015
Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonistsDaniel Glicklich, William H Frishman
Pageof 186